| 发明名称 |
Low anticoagulant heparins |
| 摘要 |
The present invention relates to a chemically modified heparin, with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw) between about 6.5 and 9.5 kDa. Also disclosed is a method of preparing the heparin and its medical use, including treatment of malaria. |
| 申请公布号 |
AU2012354226(B2) |
申请公布日期 |
2017.01.12 |
| 申请号 |
AU20120354226 |
申请日期 |
2012.12.19 |
| 申请人 |
Modus Therapeutics AB |
发明人 |
Ekre, Hans-Peter;Lindahl, Ulf;Holmer, Erik;Eriksson, Per-Olov;Leitgeb, Anna;Wahlgren, Mats;Tidia, Stefania;Liverani, Lino |
| 分类号 |
C08B37/10;A61K31/727;A61P33/06 |
主分类号 |
C08B37/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
